Virtu Financial’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-817
| Closed | -$6K | – | 1698 |
|
|
2024
Q2 | $6K | Buy |
+817
| New | +$6K | ﹤0.01% | 1174 |
|
|
2024
Q1 | – | Sell |
-3,258
| Closed | -$35K | – | 1838 |
|
|
2023
Q4 | $35K | Buy |
+3,258
| New | +$35K | ﹤0.01% | 1230 |
|
|
2023
Q3 | – | Sell |
-1,806
| Closed | -$33K | – | 1668 |
|
|
2023
Q2 | $33K | Buy |
+1,806
| New | +$33K | ﹤0.01% | 1187 |
|
|
2023
Q1 | – | Sell |
-2,882
| Closed | -$72K | – | 1869 |
|
|
2022
Q4 | $72K | Buy |
2,882
+2,357
| +449% | +$58.9K | 0.01% | 1020 |
|
|
2022
Q3 | $17K | Sell |
525
-1,314
| -71% | -$42.5K | ﹤0.01% | 1434 |
|
|
2022
Q2 | $73K | Buy |
+1,839
| New | +$73K | 0.01% | 1011 |
|
|
2022
Q1 | – | Sell |
-1,694
| Closed | -$86K | – | 1828 |
|
|
2021
Q4 | $86K | Sell |
1,694
-2,923
| -63% | -$148K | 0.01% | 1187 |
|
|
2021
Q3 | $300K | Buy |
+4,617
| New | +$300K | 0.03% | 714 |
|
|
2021
Q1 | – | Sell |
-941
| Closed | -$64K | – | 1873 |
|
|
2020
Q4 | $64K | Buy |
+941
| New | +$64K | 0.01% | 1181 |
|
|
2019
Q4 | $333K | Buy |
+2,935
| New | +$333K | 0.03% | 620 |
|
|
2019
Q3 | – | Sell |
-594
| Closed | -$25K | – | 1676 |
|
|
2019
Q2 | $25K | Sell |
594
-1,739
| -75% | -$73.2K | ﹤0.01% | 1302 |
|
|
2019
Q1 | $127K | Buy |
2,333
+1,037
| +80% | +$56.5K | 0.01% | 1081 |
|
|
2018
Q4 | $39K | Buy |
+1,296
| New | +$39K | ﹤0.01% | 1294 |
|
|
2018
Q1 | – | Sell |
-2,123
| Closed | -$123K | – | 2357 |
|
|
2017
Q4 | $123K | Buy |
2,123
+1,184
| +126% | +$68.6K | 0.01% | 1848 |
|
|
2017
Q3 | $62K | Buy |
+939
| New | +$62K | ﹤0.01% | 2193 |
|